Clinical Trial

HSK3486 (Cipepofol) Injectable Emulsion for Induction of General Anesthesia in Pediatric Subjects Undergoing Elective Surgery

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This multicenter, randomized, double-blinded, propofol-controlled Phase 3b study enrolls pediatric subjects aged 3-17 years undergoing elective surgery with endotracheal intubation. Its primary purpose is to evaluate whether cipepofol is non-inferior to propofol in success of induction of general anesthesia in pediatrics undergoing elective surgery.
Trial Details
NCT Number NCT07510945
Lead Sponsor Haisco Pharmaceutical Group Co., Ltd.
Conditions General Anesthetic
Enrollment 400 participants
Start Date 2026-05
Primary Completion 2028-05 (estimated)
Study Completion 2028-05 (estimated)
Updated on ClinicalTrials.gov 2026-04-06